Updated Jul 16, 2026
Lippoldt Darin has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $3.50M.

Darin Lippoldt is the Chief Legal Officer at Neurocrine Biosciences Inc, a biotechnology company focused on neurological and endocrine diseases. He has been involved in legal and compliance matters within the biotech sector.
| Role | Chief Legal Officer |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | NBIX | NEUROCRINE BIOSCIENCES INC | S — Open-market sale [10b5-1] | 10.0K | $179.60 | $1.80M |
| 2026-07-13 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise [10b5-1] | 10.0K | $81.49 | $815K |
| 2026-06-30 | NBIX | NEUROCRINE BIOSCIENCES INC | S — Open-market sale | 1.7K | $170.81 | $289K |
| 2026-06-30 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 1.7K | $81.49 | $138K |
| 2026-06-30 | NBIX | NEUROCRINE BIOSCIENCES INC | S — Open-market sale | 8.1K | $170.03 | $1.38M |
| 2026-06-30 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 8.1K | $81.49 | $661K |
| 2026-06-30 | NBIX | NEUROCRINE BIOSCIENCES INC | S — Open-market sale | 200 | $169.56 | $34K |
| 2026-06-30 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 200 | $81.49 | $16K |
| 2026-02-17 | NBIX | NEUROCRINE BIOSCIENCES INC | G — Bona-fide gift | 365 | $0.00 | |
| 2026-02-17 | NBIX | NEUROCRINE BIOSCIENCES INC | F — Tax withholding / forfeiture | 5.4K | $124.12 | $668K |
| 2026-02-17 | NBIX | NEUROCRINE BIOSCIENCES INC | A — Grant or award | 10.0K | $0.00 | |
| 2026-02-17 | NBIX | NEUROCRINE BIOSCIENCES INC | F — Tax withholding / forfeiture | 1.1K | $124.12 | $140K |
| 2026-02-17 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 2.1K | $0.00 | |
| 2026-02-17 | NBIX | NEUROCRINE BIOSCIENCES INC | F — Tax withholding / forfeiture | 1.1K | $124.12 | $135K |
| 2026-02-17 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 2.0K | $0.00 | |
| 2026-02-17 | NBIX | NEUROCRINE BIOSCIENCES INC | F — Tax withholding / forfeiture | 967 | $123.10 | $119K |
| 2026-02-17 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 1.8K | $0.00 | |
| 2026-02-03 | NBIX | NEUROCRINE BIOSCIENCES INC | F — Tax withholding / forfeiture | 1.3K | $136.06 | $182K |
| 2026-02-03 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 2.4K | $0.00 |
Darin Lippoldt is the Chief Legal Officer at Neurocrine Biosciences Inc, a biotechnology company focused on neurological and endocrine diseases. He has been involved in legal and compliance matters within the biotech sector.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($3.50M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lippoldt Darin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.